PMC:7647877 / 33599-33934 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T376","span":{"begin":222,"end":227},"obj":"Body_part"}],"attributes":[{"id":"A376","pred":"fma_id","subj":"T376","obj":"http://purl.org/sig/ont/fma/fma67264"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T200","span":{"begin":326,"end":334},"obj":"Disease"}],"attributes":[{"id":"A200","pred":"mondo_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T407","span":{"begin":258,"end":259},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T328","span":{"begin":222,"end":227},"obj":"Chemical"}],"attributes":[{"id":"A328","pred":"chebi_id","subj":"T328","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T209","span":{"begin":0,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"891","span":{"begin":170,"end":178},"obj":"Species"},{"id":"895","span":{"begin":222,"end":227},"obj":"Chemical"},{"id":"900","span":{"begin":164,"end":169},"obj":"Disease"},{"id":"901","span":{"begin":326,"end":334},"obj":"Disease"}],"attributes":[{"id":"A891","pred":"tao:has_database_id","subj":"891","obj":"Tax:9606"},{"id":"A895","pred":"tao:has_database_id","subj":"895","obj":"MESH:D008055"},{"id":"A900","pred":"tao:has_database_id","subj":"900","obj":"MESH:D009765"},{"id":"A901","pred":"tao:has_database_id","subj":"901","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Nowadays, discovering therapeutic options from currently available agents appears to be essential for the treatment and prophylaxis of this pandemic, especially in obese patients with comorbidities [76] and this bioactive lipid mediator can be considered as a novel potential pharmacological alternative for the management of COVID-19."}